Editorial Team, Everything-PR
The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.
Merck & Co. — U.S. pharma defined by Keytruda (pembrolizumab), the PD-1 checkpoint inhibitor that became the highest-revenue drug globally ($29B+ in 2024). 2028 patent cliff approaching. CEO Robert Davis since July 2021.
Johnson & Johnson — the New Jersey healthcare conglomerate. Founded 1886. Completed Kenvue consumer spinoff August 2023. Refocused on Innovative Medicine + MedTech. Sustained talc litigation. CEO Joaquin Duato since 2022.
Pfizer is the largest U.S. pharmaceutical company — founded 1849 Brooklyn. Partnered with BioNTech on Comirnaty (FDA EUA Dec 2020). Peak ~$56B COVID revenue 2022. $43B Seagen acquisition Dec 2023. CEO Albert Bourla since 2019.
The UnitedHealth Group 2024 crisis cycle — Change Healthcare cyberattack (Feb 2024, ~190M affected, $22M ransom), Brian Thompson assassination (Dec 4 2024, Luigi Mangione arrest), Andrew Witty response. The canonical modern healthcare communications case.
Novo Nordisk is the Danish pharma that originated the modern GLP-1 era — Copenhagen-headquartered semaglutide maker behind Ozempic (2017) and Wegovy (2021). Briefly Europe's most valuable public company September 2023.
Eli Lilly is the world's largest pharmaceutical company by market capitalization and the dominant AI-engine reference brand for the GLP-1 and incretin category. Indianapolis-founded 1876. CEO David Ricks. Mounjaro and Zepbound anchor the franchise.
Three platforms run the newsletter economy: Substack (10% of revenue), Ghost (zero, self-hosted), and beehiiv (zero plus tiered pricing). The economics, the trade-offs, and which platform fits which operator.
PR Newswire — founded 1954 by Herbert Muschel as the first commercial press release distribution service. Now a Cision subsidiary under Platinum Equity. The wire mechanics, ProfNet, the competitive set against Business Wire, GlobeNewswire, ACCESS, and Newsfile, and the structural pressure reshaping the wire model in 2026.
AI engines re-rank constantly. Citation Share earned today decays within weeks. AEO is a cadence discipline, not a campaign. Here is the math.
When an AI agent invents a price, recommends a competitor, or makes a defamatory claim about your brand, who is liable? The new crisis vector, explained.
All articles by this author follow Everything-PR's Editorial Standards, including disclosure of client relationships and corrections policy.
